Changes in typical beliefs in response to complicated grief treatment.


Journal

Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816

Informations de publication

Date de publication:
01 2020
Historique:
received: 23 04 2019
revised: 09 11 2019
accepted: 28 11 2019
pubmed: 6 12 2019
medline: 6 6 2020
entrez: 6 12 2019
Statut: ppublish

Résumé

Prolonged grief disorder (PGD) is a new diagnosis in the 11th edition of the International Classification of Diseases, estimated to affect 1 in 10 bereaved people and causing significant distress and impairment. Maladaptive thoughts play an important role in PGD. We have previously validated the typical beliefs questionnaire (TBQ), which contains five kinds of thinking commonly seen in PGD: protesting the death, negative thoughts about the world, needing the person, less grief is wrong, and grieving too much. The current paper examines the role of maladaptive cognition as measured by the TBQ in PGD and its change with treatment. Among participants in a multisite clinical trial including 394 adults, we examined (a) the relationship between maladaptive thoughts at baseline and treatment outcomes, (b) the relationship between maladaptive thoughts and suicidality at baseline and posttreatment, and (c) the effect of treatment with and without complicated grief therapy (CGT) on maladaptive thinking. TBQ scores were associated with treatment outcomes and were strongly related to suicidal thinking before and after treatment. TBQ scores showed significantly greater reduction in participants who received CGT with citalopram versus citalopram alone (adjusted mean standard error [SE] difference, -2.45 [0.85]; p = .004) and those who received CGT with placebo versus placebo alone (adjusted mean [SE] difference, -3.44 [0.90]; p < .001). Maladaptive thoughts, as measured by the TBQ, have clinical and research significance for PGD and its treatment.

Sections du résumé

BACKGROUND
Prolonged grief disorder (PGD) is a new diagnosis in the 11th edition of the International Classification of Diseases, estimated to affect 1 in 10 bereaved people and causing significant distress and impairment. Maladaptive thoughts play an important role in PGD. We have previously validated the typical beliefs questionnaire (TBQ), which contains five kinds of thinking commonly seen in PGD: protesting the death, negative thoughts about the world, needing the person, less grief is wrong, and grieving too much. The current paper examines the role of maladaptive cognition as measured by the TBQ in PGD and its change with treatment.
METHODS
Among participants in a multisite clinical trial including 394 adults, we examined (a) the relationship between maladaptive thoughts at baseline and treatment outcomes, (b) the relationship between maladaptive thoughts and suicidality at baseline and posttreatment, and (c) the effect of treatment with and without complicated grief therapy (CGT) on maladaptive thinking.
RESULTS
TBQ scores were associated with treatment outcomes and were strongly related to suicidal thinking before and after treatment. TBQ scores showed significantly greater reduction in participants who received CGT with citalopram versus citalopram alone (adjusted mean standard error [SE] difference, -2.45 [0.85]; p = .004) and those who received CGT with placebo versus placebo alone (adjusted mean [SE] difference, -3.44 [0.90]; p < .001).
CONCLUSIONS
Maladaptive thoughts, as measured by the TBQ, have clinical and research significance for PGD and its treatment.

Identifiants

pubmed: 31804005
doi: 10.1002/da.22981
pmc: PMC6952544
mid: NIHMS1062457
doi:

Substances chimiques

Citalopram 0DHU5B8D6V

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-89

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH060783
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085297
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085308
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085288
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Br J Clin Psychol. 2015 Jun;54(2):163-80
pubmed: 25229192
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Psychiatr Serv. 2001 Aug;52(8):1069-74
pubmed: 11474053
Death Stud. 2002 Dec;26(10):781-92
pubmed: 12440418
Psychiatry Res. 1995 Nov 29;59(1-2):65-79
pubmed: 8771222
Depress Anxiety. 2015 Jul;32(7):485-92
pubmed: 26061724
J Affect Disord. 2012 Mar;137(1-3):117-24
pubmed: 22240087
Death Stud. 2017 May-Jun;41(5):267-275
pubmed: 27892842
J Affect Disord. 2018 Dec 1;241:360-366
pubmed: 30144719
J Affect Disord. 2017 Apr 01;212:138-149
pubmed: 28167398
Suicide Life Threat Behav. 2004 Winter;34(4):350-62
pubmed: 15585457
Am J Geriatr Psychiatry. 2017 May;25(5):541-550
pubmed: 27793576
Behav Res Ther. 2009 Jul;47(7):616-22
pubmed: 19394589
J Affect Disord. 2018 Feb;227:338-344
pubmed: 29136603
J Abnorm Psychol. 2013 Nov;122(4):961-70
pubmed: 24364599
Stat Med. 2012 Dec 10;31(28):3433-43
pubmed: 22829439
J Clin Psychiatry. 2014 Oct;75(10):1040-6
pubmed: 25006812
Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
J Clin Psychiatry. 2006 Feb;67(2):233-9
pubmed: 16566618
J Consult Clin Psychol. 2004 Oct;72(5):879-84
pubmed: 15482045
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
J Affect Disord. 2015 Jan 1;170:15-21
pubmed: 25217759
JAMA. 2005 Jun 1;293(21):2601-8
pubmed: 15928281
J Nerv Ment Dis. 2011 Dec;199(12):921-7
pubmed: 22134449
Psychiatry Res. 2016 Jun 30;240:358-363
pubmed: 27138832
Fam Pract. 2019 Mar 20;36(2):125-131
pubmed: 29860527
J Affect Disord. 2011 Jun;131(1-3):339-43
pubmed: 21216470
J Consult Clin Psychol. 2017 Sep;85(9):873-882
pubmed: 28504542
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Behav Res Ther. 2006 Feb;44(2):219-31
pubmed: 16389062
JAMA Psychiatry. 2014 Nov;71(11):1287-95
pubmed: 25250737
Perspect Psychol Sci. 2008 Sep;3(5):400-24
pubmed: 26158958
Behav Ther. 2017 Mar;48(2):156-165
pubmed: 28270327
JAMA Psychiatry. 2016 Jul 1;73(7):685-94
pubmed: 27276373
J Consult Clin Psychol. 2014 Feb;82(1):171-5
pubmed: 24188512

Auteurs

Natalia A Skritskaya (NA)

School of Social Work, Columbia University, New York, New York.

Christine Mauro (C)

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York.

Angel Garcia de la Garza (A)

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York.

Franziska Meichsner (F)

Department of Clinical Psychology and Psychotherapy, Institute of Psychology, Goethe University, Frankfurt, Germany.

Barry Lebowitz (B)

Department of Psychiatry, University of California San Diego and San Diego Healthcare System, San Diego, California.

Charles F Reynolds (CF)

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Naomi M Simon (NM)

Department of Psychiatry, NYU Langone Health, New York University School of Medicine, New York, New York.

Sidney Zisook (S)

Department of Psychiatry, University of California San Diego and San Diego Healthcare System, San Diego, California.

M Katherine Shear (MK)

School of Social Work, Columbia University, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH